Last update 08 May 2025

CACNA2D2 x COX-2 x CACNA2D1

Basic Info

Related Targets
CACNA2D2COX-2CACNA2D1

Related

1
Drugs associated with CACNA2D2 x COX-2 x CACNA2D1
CG-651
Target
CACNA2D1 x CACNA2D2 x COX-2
Mechanism
CACNA2D1 blockers [+2]
Active Org.-
Originator Org.
CG Invites Co., Ltd.CG Invites Co., Ltd.
Active Indication-
Inactive Indication-
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with CACNA2D2 x COX-2 x CACNA2D1
NCT05370716
/ CompletedPhase 1
A Randomized, Open-label, Multiple-dose, Parallel Study to Compare the Pharmacokinetics and to Evaluate Drug-Drug Interaction of "CG-651" in Healthy Volunteers
100 Clinical Results associated with CACNA2D2 x COX-2 x CACNA2D1
Login to view more data
100 Translational Medicine associated with CACNA2D2 x COX-2 x CACNA2D1
Login to view more data
0 Patents (Medical) associated with CACNA2D2 x COX-2 x CACNA2D1
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free